1. Division of Cell and Molecular Biology, Imperial College London, London, United Kingdom;
2. Manchester Collaborative Centre for Inflammation Research, Core Technology Facility, University of Manchester, Manchester, United Kingdom; and
3. MedImmune Ltd, Cambridge, United Kingdom